From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...
Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP) NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bionic Sight, Inc., a company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results